Midgut Neuroendocrine Tumor — knowledge graph · CancerIndex

Knowledge graph · Cancer

Midgut Neuroendocrine Tumor

subtype

Identifier: CI-CAN-00003343
Entity page: /cancer/midgut-neuroendocrine-tumor ↗
Edges: 10

Neighbours: 4 drugs6 trials
Drawn: 10 of 10 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Midgut Neuroendocrine Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Abemaciclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Midgut Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Capecitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Midgut Neuroendocrine Tumor studied in …STUDIED_INderived6 of 6
→ studied in	NCT01841736Phase 2 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 6 trials mapped (3 active)	—	—	Midgut Neuroendocrine Tumor G1	1	Observed	clinicaltrials	graph →
→ studied in	NCT03891784Phase 2 · active not recruiting Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 6 trials mapped (3 active)	—	—	Midgut Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT04735198NA · recruiting Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. · condition mapped ALIAS · 6 trials mapped (3 active)	—	—	Midgut Neuroendocrine Tumor G1	1	Observed	clinicaltrials	graph →
→ studied in	NCT03667092NA · completed Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 6 trials mapped (3 active)	—	—	Midgut Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02651987Phase 2 · completed Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg · condition mapped ONTOLOGY_EXACT · 6 trials mapped (3 active)	—	—	Midgut Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT02358356Phase 2 · completed Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study · condition mapped ONTOLOGY_EXACT · 6 trials mapped (3 active)	—	—	Midgut Neuroendocrine Tumor	1	Observed	clinicaltrials	graph →